| dc.contributor.author | Leblebicioglu, Hakan | |
| dc.contributor.author | Ozaras, Resat | |
| dc.contributor.author | Sunbul, Mustafa | |
| dc.date.accessioned | 2020-06-21T13:46:05Z | |
| dc.date.available | 2020-06-21T13:46:05Z | |
| dc.date.issued | 2015 | |
| dc.identifier.issn | 1473-3099 | |
| dc.identifier.issn | 1474-4457 | |
| dc.identifier.uri | https://doi.org/10.1016/S1473-3099(15)00076-6 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12712/14239 | |
| dc.description | Leblebicioglu, Hakan/0000-0002-6033-8543 | en_US |
| dc.description | WOS: 000356622900019 | en_US |
| dc.description | PubMed: 26122444 | en_US |
| dc.description.abstract | … | en_US |
| dc.language.iso | eng | en_US |
| dc.publisher | Elsevier Sci Ltd | en_US |
| dc.relation.isversionof | 10.1016/S1473-3099(15)00076-6 | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.title | Role of co-trimoxazole for urinary tract infections in developing countries | en_US |
| dc.type | letter | en_US |
| dc.contributor.department | OMÜ | en_US |
| dc.identifier.volume | 15 | en_US |
| dc.identifier.issue | 7 | en_US |
| dc.identifier.startpage | 764 | en_US |
| dc.identifier.endpage | 765 | en_US |
| dc.relation.journal | Lancet Infectious Diseases | en_US |
| dc.relation.publicationcategory | Diğer | en_US |
